Kirk Wheeler Michel - 04 Jan 2022 Form 4 Insider Report for Pharma-Bio Serv, Inc. (PBSV)

Role
Chairman, Director
Signature
/s/ Kirk Michel
Issuer symbol
PBSV
Transactions as of
04 Jan 2022
Net transactions value
-$0.1
Form type
4
Filing time
05 Jan 2022, 19:14:48 UTC
Next filing
12 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBSV Common Stock Options Exercise $18,200 +20,000 +61% $0.9100 52,706 04 Jan 2022 Direct
transaction PBSV Common Stock Tax liability $18,200 -17,670 -34% $1.03 35,036 04 Jan 2022 Direct F1, F2
holding PBSV Common Stock 340,706 04 Jan 2022 By Kema Advisors, Inc. F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBSV Stock Option Options Exercise $0 -20,000 -100% $0.000000* 0 04 Jan 2022 Common Stock 20,000 $0.9100 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
F2 Shares reported in this column have been updated to properly reflect the shares held by the reporting person following the transactions on January 4, 2021.
F3 The reporting person is the sole shareholder of this entity.
F4 The option vested in two equal installments on July 10, 2017 and July 10, 2018.